279 related articles for article (PubMed ID: 1951111)
1. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
[TBL] [Abstract][Full Text] [Related]
2. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
3. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
[TBL] [Abstract][Full Text] [Related]
4. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1996 Feb; 93(4):691-6. PubMed ID: 8640997
[TBL] [Abstract][Full Text] [Related]
5. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.
Schaer DH; Buff LA; Katz RJ
Am J Cardiol; 1988 Jan; 61(1):46-50. PubMed ID: 3122549
[TBL] [Abstract][Full Text] [Related]
6. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
[TBL] [Abstract][Full Text] [Related]
7. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.
Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP
Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732
[TBL] [Abstract][Full Text] [Related]
8. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
9. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time.
Frishman WH; Giles T; Greenberg S; Heiman M; Raffidal L; Soberman J; Laifer L; Nadelmann J; Lazar E; Strom J
J Clin Pharmacol; 1989 Dec; 29(12):1097-105. PubMed ID: 2515215
[TBL] [Abstract][Full Text] [Related]
10. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
DeMots H; Glasser SP
J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
[TBL] [Abstract][Full Text] [Related]
11. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
Thadani U; Hamilton SF; Olson E; Anderson J; Voyles W; Prasad R; Teague SM
Ann Intern Med; 1986 Oct; 105(4):485-92. PubMed ID: 3092711
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.
de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A
Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943
[TBL] [Abstract][Full Text] [Related]
13. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
Rezaković DE; Pavicić L; Majacić M
Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group.
Scardi S; Camerini F; Pandullo C; Pollavini G
Int J Cardiol; 1991 Aug; 32(2):241-8. PubMed ID: 1917174
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.
Whalley DW; Hellestrand KJ
Aust N Z J Med; 1990 Oct; 20(5):677-81. PubMed ID: 2126727
[TBL] [Abstract][Full Text] [Related]
18. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia.
Rossetti E; Luca C; Bonetti F; Chierchia SL
J Am Coll Cardiol; 1993 Feb; 21(2):337-42. PubMed ID: 8425995
[TBL] [Abstract][Full Text] [Related]
19. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.
Luke R; Sharpe N; Coxon R
J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351
[TBL] [Abstract][Full Text] [Related]
20. Discontinuous transdermal nitroglycerin as treatment for stable angina in the elderly: a double-blind multicentre study. The Transdermal TNG Trial Group of Istituto Nazionale Ricovero e Cura Anziani (I.N.R.C.A.).
Paciaroni E; Luca C
Eur Heart J; 1991 Oct; 12(10):1076-80. PubMed ID: 1782932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]